MKM Partners is lowering its fair value estimate on Amarin (Nasdaq: AMRN) from $2 down to $1.50, while maintaining the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Second-Half Vascepa Sales Growth Still in Focus for Amarin (AMRN); Aegis Maintains at 'Hold'May 12, 2014 9:31 AM UPDATE: Citi Downgrades Amarin Corporation (AMRN) to NeutralMay 12, 2014 6:42 AM Amarin Corp Plc (AMRN) Posts Q1 Loss of 16c/Share; Updates on OpsMay 9, 2014 7:03 AM